Published in Neuropsychopharmacology on May 01, 2000
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry (2008) 1.80
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) (2004) 1.66
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol (2010) 1.38
Developing human laboratory models of smoking lapse behavior for medication screening. Addict Biol (2008) 1.26
Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend (2009) 1.16
Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci (2001) 1.09
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res (2009) 1.06
Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol (2013) 1.02
Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology (Berl) (2003) 1.01
Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res (2008) 1.00
Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation. Int J Neuropsychopharmacol (2008) 1.00
GABRA2 markers moderate the subjective effects of alcohol. Addict Biol (2012) 0.96
Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcohol Clin Exp Res (2011) 0.94
The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. Alcohol Clin Exp Res (2010) 0.94
The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study. Front Psychiatry (2010) 0.93
Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacol Biochem Behav (2009) 0.93
Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol (2010) 0.92
Alcohol calibration of tests measuring skills related to car driving. Psychopharmacology (Berl) (2014) 0.90
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone. Am J Addict (2010) 0.88
Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons. Psychopharmacology (Berl) (2012) 0.84
Interaction between family history of alcoholism and Locus of Control in the opioid regulation of impulsive responding under the influence of alcohol. Alcohol Clin Exp Res (2011) 0.84
Examining naltrexone and alcohol effects in a minority population: results from an initial human laboratory study. Am J Addict (2011) 0.84
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. Neurobiol Learn Mem (2008) 0.83
Blocking opioids attenuates physical warmth-induced feelings of social connection. Emotion (2015) 0.81
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol (2016) 0.80
Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence. J Consult Clin Psychol (2015) 0.80
The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects. Alcohol (2012) 0.78
Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains. Psychopharmacology (Berl) (2014) 0.77
Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behav Res Ther (2016) 0.75
A paradigm for examining stress effects on alcohol-motivated behaviors in participants with alcohol use disorder. Addict Biol (2017) 0.75
Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control (2004) 5.97
Patterns of waterpipe use and dependence: implications for intervention development. Pharmacol Biochem Behav (2004) 3.51
Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int (2007) 2.92
Factors related to frequency of narghile (waterpipe) use: the first insights on tobacco dependence in narghile users. Drug Alcohol Depend (2004) 2.66
Prevalence and characteristics of narghile smoking among university students in Syria. Int J Tuberc Lung Dis (2004) 2.38
Encouraging patients to become more physically active: the physician's role. Ann Intern Med (1997) 2.37
Body weight and health care among women in the general population. Arch Fam Med (1998) 2.26
A pleasure among friends: how narghile (waterpipe) smoking differs from cigarette smoking in Syria. Tob Control (2008) 2.25
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev (2007) 2.21
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tob Control (2009) 2.17
The tobacco epidemic in Syria. Tob Control (2006) 2.06
Acute subjective and physiological responses to smoking in adolescents. Addiction (2001) 1.87
Standardizing questionnaire items for the assessment of waterpipe tobacco use in epidemiological studies. Public Health (2005) 1.75
Gender and smoking status-based analysis of views regarding waterpipe and cigarette smoking in Aleppo, Syria. Prev Med (2004) 1.71
Opioids and alcoholism. Physiol Behav (2004) 1.67
The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry (1999) 1.67
Evaluation of Hawaii's Healthy Start Program. Future Child (1999) 1.63
Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab (2009) 1.63
Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers. Alcohol Clin Exp Res (2000) 1.62
Sterile epidural and bilateral psoas abscesses in a patient with Crohn's disease. Am J Gastroenterol (1994) 1.59
Health-related quality of life in obese persons seeking treatment. J Fam Pract (1996) 1.59
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend (1995) 1.54
Acute effects of Advance: a potential reduced exposure product for smokers. Tob Control (2002) 1.50
Adapting smoking cessation interventions for developing countries: a model for the Middle East. Int J Tuberc Lung Dis (2004) 1.49
Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol (1994) 1.49
The longer-term effectiveness of residential lead paint abatement. Environ Res (1994) 1.38
Bilateral simultaneous cavernous sinus sampling using corticotropin-releasing hormone in the evaluation of Cushing disease. AJNR Am J Neuroradiol (1996) 1.38
Impact of weight loss on health-related quality of life. Qual Life Res (1999) 1.38
Diverticular disease in the elderly. J Am Geriatr Soc (1993) 1.37
Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes. Nicotine Tob Res (2001) 1.35
Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab (2001) 1.35
Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes (1998) 1.30
Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology (1990) 1.29
Environmental lead exposure during early life alters granule cell neurogenesis and morphology in the hippocampus of young adult rats. Neuroscience (2007) 1.27
Pain in the obese: impact on health-related quality-of-life. Ann Behav Med (1997) 1.25
Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc (1989) 1.20
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr (2001) 1.20
Characteristics of cigarette smoking and quitting among university students in Syria. Prev Med (2004) 1.14
Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacology (Berl) (2001) 1.13
Method for prolonged ambulatory monitoring of high-amplitude propagated contractions from colon. Am J Physiol (1991) 1.13
Social impairments in Rett syndrome: characteristics and relationship with clinical severity. J Intellect Disabil Res (2011) 1.11
Waterpipe tobacco and cigarette smoking among university students in Jordan. Int J Tuberc Lung Dis (2012) 1.10
GABRA6 gene polymorphism and an attenuated stress response. Mol Psychiatry (2004) 1.09
Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation. Neuropsychopharmacology (2001) 1.08
Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases. Gastroenterology (1984) 1.04
Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance. Tob Control (2003) 1.04
Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav (1998) 1.03
Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior. Nicotine Tob Res (2000) 1.02
Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters. Am J Gastroenterol (1994) 1.02
Soil lead abatement and children's blood lead levels in an urban setting. Am J Public Health (1998) 0.97
Influence of serum cholesterol and albumin on partitioning of PCB congeners between human serum and adipose tissue. Toxicol Appl Pharmacol (1987) 0.97
Use of preventive health care services by patients with obesity. Obes Res (1999) 0.97
The time for tobacco industry sponsored PREP evaluation has arrived. Tob Control (2006) 0.96
Self-efficacy, attendance, and weight loss in obesity treatment. Addict Behav (1997) 0.95
The effects of mild ethanol intoxication on the hypothalamic-pituitary-adrenal axis in nonalcoholic men. J Clin Endocrinol Metab (1993) 0.92
Optimism and obesity treatment outcomes. J Clin Psychol (1999) 0.92
Ophthalmic involvement in aggressive histiocytosis X. Ophthalmology (1990) 0.91
Predicting treatment attendance and weight loss: assessing the psychometric properties and predictive validity of the Dieting Readiness Test. J Pers Assess (1997) 0.91
Constipation in the elderly. Am Fam Physician (1998) 0.91
Comparison of a wipe and a vacuum collection method for the determination of lead in residential dusts. Environ Res (1994) 0.90
Genetic ascertainment with heterogeneous risk. Am J Med Genet (1987) 0.90
Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance. Diabetes (1999) 0.90
Disorders of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol Metab (1985) 0.90
Corticotropin-independent Cushing's syndrome caused by an ectopic adrenal adenoma. J Clin Endocrinol Metab (2000) 0.89
The fate of the rectal segment after diversion of the fecal stream in Crohn's disease: its implications for surgical management. J Clin Gastroenterol (1985) 0.88
Case report: acromegaly and Cushing's disease in a patient with synchronous pituitary adenomas. Am J Med Sci (1992) 0.88
Chronic ethanol administration decreases phosphorylation of cyclic AMP response element-binding protein in granule cells of rat cerebellum. J Neurochem (1998) 0.88
Increased expression of Gs(alpha) enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol (1997) 0.88
Placebo control study of acute smokeless tobacco abstinence in young adult men. Psychol Addict Behav (2000) 0.88
Exposure to secondhand smoke at home and in public places in Syria: a developing country's perspective. Inhal Toxicol (2008) 0.87
The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes (1997) 0.87
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. Drug Alcohol Depend (1995) 0.87
Hereditary polyposis coli. III. Genetic and evolutionary fitness. Am J Hum Genet (1980) 0.86
Chronic ethanol exposure impairs phosphorylation of CREB and CRE-binding activity in rat striatum. Alcohol Clin Exp Res (1998) 0.86
Ethane: a marker of lipid peroxidation during cardiopulmonary bypass in humans. Free Radic Biol Med (1999) 0.85
Characterization of a peptide alpha-amidation activity in human plasma and tissues. Metabolism (1985) 0.84
Adenylyl cyclase signal transduction and alcohol-induced sedation. Pharmacol Biochem Behav (1997) 0.84
Diabetes insipidus. Crit Care Med (1992) 0.83
Predictors of quality of life for obese persons. J Nerv Ment Dis (1997) 0.83
Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects. Alcohol Clin Exp Res (1994) 0.83
Behavioral approaches to the problems of obesity. Behav Modif (2000) 0.82
Weight-control behaviors among adults and adolescents: associations with dietary intake. Prev Med (2000) 0.82
Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tob Control (2009) 0.81
Effect of childhood obesity prevention programmes on blood lipids: a systematic review and meta-analysis. Obes Rev (2014) 0.81
Enhanced expression of the inhibitory protein Gi2 alpha and decreased activity of adenylyl cyclase in lymphocytes of abstinent alcoholics. Alcohol Clin Exp Res (1993) 0.81
Body mass index, smoking, and mortality among older American women. J Womens Health (1998) 0.80
Support group membership and perceptions of control over health in HIV+ men. J Clin Psychol (1997) 0.80
Ethanol exposure alters the phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element binding activity in rat cerebellum. J Pharmacol Exp Ther (1996) 0.79
Changes in diet, weight, and serum lipid levels associated with olestra consumption. Arch Intern Med (2000) 0.79
Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signaling in regenerating rat liver. Hepatology (1992) 0.79
Isoluminance and contingent color aftereffects. Percept Psychophys (1997) 0.78
Polymorphism of the gene encoding the alpha subunit of the stimulatory G-protein of adenylyl cyclase (GNAS1). Hum Genet (1994) 0.78
Cardiovascular responses to naloxone challenge in opiate-dependent individuals. Pharmacol Biochem Behav (1992) 0.78
Characterization of peptide alpha-amidation activity in human cerebrospinal fluid and central nervous system tissue. Neuroendocrinology (1985) 0.77
Plasma adrenocorticotropin responses to opioid blockade with naloxone: generating a dose-response curve in a single session. Biol Psychiatry (2000) 0.77